SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

16 May 2024 Evaluate
The revenue for the March 2024 quarter is pegged at Rs. 5326.00 millions, about 5.11% up against Rs. 5067.00 millions recorded during the year-ago period.Net Profit for the quarter ended March 2024 dipped to Rs. 140.00  millions from Rs. 18108.00 millions  in the corresponding previous quarter.The company reported a good operating profit of 911.00 millions compared to 200.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5326.00 5067.00 5.11 21273.00 19929.00 6.74 21273.00 19929.00 6.74
Other Income 389.00 640.00 -39.22 1930.00 2714.00 -28.89 1930.00 2714.00 -28.89
PBIDT 911.00 200.00 355.50 4557.00 2949.00 54.53 4557.00 2949.00 54.53
Interest 395.00 481.00 -17.88 1988.00 696.00 185.63 1988.00 696.00 185.63
PBDT 516.00 18255.00 -97.17 2714.00 30881.00 -91.21 2714.00 30881.00 -91.21
Depreciation 298.00 294.00 1.36 1211.00 1169.00 3.59 1211.00 1169.00 3.59
PBT 218.00 17961.00 -98.79 1503.00 29712.00 -94.94 1503.00 29712.00 -94.94
TAX 78.00 -147.00 -153.06 310.00 1228.00 -74.76 310.00 1228.00 -74.76
Deferred Tax 171.00 -18.00 -1050.00 159.00 -99.00 -260.61 159.00 -99.00 -260.61
PAT 140.00 18108.00 -99.23 1193.00 28484.00 -95.81 1193.00 28484.00 -95.81
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 17.10 3.95 333.35 21.42 14.80 44.76 21.42 14.80 44.76

Biocon Share Price

358.20 7.65 (2.18%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×